ALGS vs MTB · rev $3.6M vs P/E 12, $30.99B cap
Aligos Therapeutics Inc (ALGS) versus M&T Bank Corporation (MTB) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
MTB does not have a complete income-statement cache yet.
ALGS currently screens at market cap $44.1M. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
Not investment advice. Open the ALGS and MTB stock pages for the full models.
Not investment advice.